PARP
PARP(多聚ADP核糖聚合酶)
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
PARP 相关产品(118)
- GC10145PJ34 hydrochlorideCAS: 344458-15-7纯度: >99.00%
PJ34 hydrochloride是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。
- GC12422ABT-888 (Veliparib)CAS: 912444-00-9纯度: >99.50% / >98.00%
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂,Ki分别为5.2和2.9nM。
- GC15955Rucaparib (AG-014699,PF-01367338) phosphateCAS: 459868-92-9纯度: >99.50%
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。
- GC17580Olaparib (AZD2281, Ku-0059436)CAS: 763113-22-0纯度: >99.50% / >98.00%
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。
- GC13249Rucaparib (free base)CAS: 283173-50-2纯度: >99.00%
Rucaparib (free base)是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10145 | PJ34 hydrochloride | 344458-15-7 | >99.00% | |
PJ34 hydrochloride是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。 | ||||
| GC12422 | ABT-888 (Veliparib) | 912444-00-9 | >99.50% / >98.00% | |
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂,Ki分别为5.2和2.9nM。 | ||||
| GC12781 | XAV-939 | 284028-89-3 | >98.50% / >98.00% | |
XAV-939 选择性抑制 β-连环蛋白介导的转录。 | ||||
| GC15353 | Iniparib (BSI-201) | 160003-66-7 | >99.50% | |
A PARP1 inhibitor | ||||
| GC15932 | BMN 673 | 1207456-01-6 | >98.50% | |
BMN 673是一种新型且高效的聚ADP核糖聚合酶1和2(PARP1/2)抑制剂,对PARP1的K i 为1.2nM,对PARP2的K i 为0.87nM。 | ||||
| GC15955 | Rucaparib (AG-014699,PF-01367338) phosphate | 459868-92-9 | >99.50% | |
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。 | ||||
| GC16318 | AG-14361 | 328543-09-5 | >99.00% | |
A PARP1 inhibitor | ||||
| GC17580 | Olaparib (AZD2281, Ku-0059436) | 763113-22-0 | >99.50% / >98.00% | |
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。 | ||||
| GC17965 | AZD2461 | 1174043-16-3 | >98.00% | |
A PARP inhibitor | ||||
| GC10456 | Fucosterol | 17605-67-3 | >98.00% | |
A natural phytosterol with diverse biological activities | ||||
| GC10995 | PJ34 | 344458-19-1 | >98.00% | |
PJ34是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。 | ||||
| GC11548 | Tankyrase Inhibitors (TNKS) 49 | - | - | |
Tankyrase inhibitor | ||||
| GC12496 | INO-1001 | 3544-24-9 | >99.50% | |
A PARP inhibitor | ||||
| GC12869 | JW 55 | 664993-53-7 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC13249 | Rucaparib (free base) | 283173-50-2 | >99.00% | |
Rucaparib (free base)是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。 | ||||
| GC13419 | ME0328 | 1445251-22-8 | >99.50% | |
A selective PARP3 inhibitor | ||||
| GC13541 | G007-LK | 1380672-07-0 | >99.00% | |
G007-LK是一种有效的、选择性的TNKS1(IC 50 =46nM)和TNKS2(IC 50 =25nM)抑制剂。 | ||||
| GC14380 | BGP-15 | 66611-37-8 | >98.00% | |
A PARP inhibitor and insulin sensitizer | ||||
| GC15041 | Tankyrase Inhibitors (TNKS) 22 | - | - | |
Tankyrase inhibitor | ||||
| GC16725 | AZ6102 | 1645286-75-4 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC16914 | MN 64 | 92831-11-3 | >99.50% | |
A TNKS inhibitor | ||||
| GC17555 | NVP-TNKS656 | 1419949-20-4 | >98.00% | |
A TNKS2 inhibitor | ||||
| GC18172 | E7449 | 1140964-99-3 | >98.00% | |
An inhibitor of PARP1, PARP2, and TNKS1/2 | ||||
| GC19264 | NMS-P118 | 1262417-51-5 | >99.50% | |
A potent and selective PARP1 inhibitor | ||||
